Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-032580

Chief Executive Officer bought 5,000 shares at $14.34 ($71,700)

From the SEC's structured data for this filing

Trades in this filing

Ward Robert · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-05-22 Purchase : show line 1 in the form +5,000 $14.34 $71,700 15,000 D
Open-market purchases · 5,000 sh · avg $14.34 · $71,700
Loading xslF345X03/doc4.xml…